Large gap with delayed quotes
|
Last quote
01/15/2026
-
17:03:25
|
Bid
01/15/2026 -
17:03:47
|
Bid Volume |
Ask
01/15/2026 -
17:04:04
|
Ask Volume |
|---|---|---|---|---|
|
11.98
-0.04
(
-0.33% )
|
11.98
|
241 |
12.00
|
222 |
Analysis date: 13.01.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 13.01.2026.
Interest
Very strong
Very strong
Four stars since 13.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.01.2026 at a price of 11.98.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 25.11.2025.
4wk Rel Perf
7.45%
7.45%
The four-week dividend-adjusted overperformance versus STOXX600 is 7.45%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.61%.
Mkt Cap in $bn
0.60
0.60
With a market capitalization <$2bn, MEDMIX AG is considered a small-cap stock.
G/PE Ratio
2.33
2.33
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
17.74
17.74
The estimated PE is for the year 2027.
LT Growth
37.20%
37.20%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
4.17%
4.17%
The twelve month estimated dividend yield represents 74.05% of earnings forecasts.
Beta
142
142
For 1% of index variation, the stock varies on average by 1.42%.
Correlation
0.45
0.45
44.86% of stock movements are explained by index variations.
Value at Risk
3.78
3.78
The value at risk is estimated at CHF 3.78. The risk is therefore 31.59%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.10.2022
21.10.2022